BSR guidelines for TNF blockers in ankylosing spondylitis--how useful are they?

Rheumatology (Oxford). 2006 Sep;45(9):1176-7; author reply 1177-8. doi: 10.1093/rheumatology/kel181. Epub 2006 Jul 4.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Guideline Adherence
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Patient Selection
  • Practice Guidelines as Topic
  • Spondylitis, Ankylosing / diagnosis
  • Spondylitis, Ankylosing / drug therapy*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha